Category: Speeches

  • Andrew Gwynne – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Andrew Gwynne – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Andrew Gwynne on 2016-09-14.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, with reference to article 3 of the UN Convention on the Law of the Sea’s classification for the breadth of the territorial seas not exceeding 12 nautical miles, for what reason Gibraltar has a three nautical mile limit on its territorial waters.

    Sir Alan Duncan

    ​The 1987 Territorial Sea Act extended UK waters up to the 12 nautical miles maximum permitted by Article 3 of the 1982 United Nations Convention on the Laws of the Sea (UNCLOS). However, the provisions of this Act were not extended to the British Overseas Territories, so the United Kingdom’s claim to territorial waters remains up to 3 nautical miles from Gibraltar. Where the extent of territorial waters is less than 3 nautical miles, this is due to the proximity of the Spanish coastline and a determined median line. We retain the option to extend the reach of British Gibraltar Territorial Waters to the maximum extent of 12 nautical miles permitted under UNCLOS and keep this option under review. The United Kingdom is the only State entitled to a territorial claim over the 3-12 nautical mile zone in respect of Gibraltar.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-11-10.

    To ask the Secretary of State for Health, if he will discuss with the Royal Colleges the potential side effects of osteoporosis drugs on (a) jaw and (b) general bone health.

    George Freeman

    As with all medicines, the Medicines and Healthcare products Regulatory Agency (MHRA) and the Government’s independent expert advisory body the Commission on Human Medicines (CHM) keep the safety of osteoporosis drugs under continual review including their effects on the jaw and on bone health. The MHRA, together with the CHM, ensures that the product information for osteoporosis medicines contains up to date information and issues updated advice as appropriate.

    Warnings about the risks of osteonecrosis of the jaw (severe bone damage in the jaw) and atypical fractures of the femur (unusual fracture of the thigh bone) are included in the product information (Summary of Product Characteristics for healthcare professionals and Patient Information Leaflet for patients) for all medicines containing bisphosphonates or denosumab which are used in the treatment of osteoporosis. New information and advice on these risks have been communicated to healthcare professionals in the MHRAsafety bulletin in 2006, 2007, 2009, 2011, 2013 and 2014 as new information has become available. A patient reminder card on the risk of osteonecrosis of the jaw is currently being introduced for patients treated with denosumab and bisphosphonates given by injection and healthcare professionals have been informed of this new measure via the MHRA bulletin.

    Information about the recognised risks of osteonecrosis of the jaw and atypical fractures of the femur with bisphosphonates and denosumab is also included in the 2014 ‘Osteoporosis – Clinical Guideline for prevention and treatment’ developed by the National Osteoporosis Guideline Group which includes the Royal College of Physicians.

  • Wayne David – 2015 Parliamentary Question to the Department of Health

    Wayne David – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Wayne David on 2015-12-10.

    To ask the Secretary of State for Health, how many prisoners are taking part in drug and alcohol treatment programmes (a) in total and (b) in each prison in England and Wales.

    Jane Ellison

    Public Health England provides local information for performance monitoring in the restricted access section of the National Drug Treatment Monitoring System website, but does not publish national data centrally.

  • Andrew Percy – 2016 Parliamentary Question to the Cabinet Office

    Andrew Percy – 2016 Parliamentary Question to the Cabinet Office

    The below Parliamentary question was asked by Andrew Percy on 2016-01-14.

    To ask the Minister for the Cabinet Office, how many defibrillators are provided in each building his Department manages.

    Matthew Hancock

    One defibrillator has been provided in each of three buildings managed by the Cabinet Office. The buildings are: 10 Downing Street; Rosebery Court, Norwich; and Emergency Planning College, York.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-02-09.

    To ask Her Majesty’s Government what estimate they made of the costs of closing NHS Direct at the time of the decision, and what was the actual cost of closing NHS Direct.

    Lord Prior of Brampton

    NHS Direct NHS Trust’s Final Report and Accounts, published in June 2014, set out decommissioning costs of £69.2 million for 2012/13. The Trust’s business case, submitted for approval of the transaction for its dissolution which took effect on 1 April 2014, included an estimated cost of closure of £36.3 million in 2014/15. The Final Report and Accounts showed the decommissioning costs for this year to be £17.6 million.

  • Gloria De Piero – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    Gloria De Piero – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    The below Parliamentary question was asked by Gloria De Piero on 2016-03-04.

    To ask the Secretary of State for Culture, Media and Sport, how many local authority-owned museums have closed down in each of the last three years.

    Mr Edward Vaizey

    Neither DCMS nor Arts Council England holds information on museums closures. However, there are just under 1800 accredited museums.

    Thanks to an excellent Spending Review settlement in November 2015, the Government is honouring its manifesto commitment to keep entry to the permanent collections of our national museums free.

    Through the Arts Council England, DCMS is increasing funding for 21 Major Partner Museums from £20.3m to £22.6 million. In addition to this, regional museums can bid for funds from ACE’s £10 million per year Resilience Fund. They can also bid for lottery funding from the HLF. We are also investing millions of pounds to boost local and regional museums, for example, £5 million towards a new South Asia Gallery at Manchester Museum and £2.5 million to the Manchester Museum of Science and Industry.

  • Imran Hussain – 2016 Parliamentary Question to the Department for International Development

    Imran Hussain – 2016 Parliamentary Question to the Department for International Development

    The below Parliamentary question was asked by Imran Hussain on 2016-04-08.

    To ask the Secretary of State for International Development, with reference to the Supporting Syria Conference 2016, to whom and by what mechanisms the Government’s funding pledges at that conference will be made.

    Mr Desmond Swayne

    At the London Conference, the Prime Minister announced that the UK will more than double our total pledge to the Syria crisis from £1.12 billion to over £2.3 billion. The UK has already spent more than £1.1 billion in providing lifesaving aid in Syria and the region.

  • Jim Cunningham – 2016 Parliamentary Question to the Department for Transport

    Jim Cunningham – 2016 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Jim Cunningham on 2016-05-09.

    To ask the Secretary of State for Transport, what assessment his Department has made of the potential economic effect of the High Speed 2 project on Coventry; and if he will make a statement.

    Mr Robert Goodwill

    Much of the research on the impacts of HS2 on specific areas of the UK so far has focussed on the HS2 named cities such as Manchester, Leeds, Birmingham and London. However, to build an understanding of the potential for HS2 to contribute to balanced economic growth in the UK, The Economic Case for HS2, published in 2013, apportioned the estimated social benefits of the project to different regions. The West Midlands was estimated to receive 15% of the benefit of the full ‘Y’ network in 2036, valued at £303m (in 2011 prices). Coventry, located close to the planned HS2 Birmingham Interchange station, can be expected to benefit from faster journey times through the high speed network as well as released capacity on the classic network.

    Early research published in the HS2 Regional Economic Impacts report in 2013 attempted to estimate the gross GVA effects of HS2 on the West Midlands economy in 2037 and produced an illustrative estimate of between £1.5bn and £3.1bn of additional output per annum (in 2013 prices). We continue to refine the methodology of how we assess regional economic impacts and build evidence on the contribution which HS2 could make to creating sustainable and balanced economic growth.

  • Andrew Rosindell – 2016 Parliamentary Question to the Cabinet Office

    Andrew Rosindell – 2016 Parliamentary Question to the Cabinet Office

    The below Parliamentary question was asked by Andrew Rosindell on 2016-06-28.

    To ask the Minister for the Cabinet Office, when his Department plans to publish its most recent data on migration to and from the UK.

    Chris Skidmore

    The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.

  • Helen Jones – 2016 Parliamentary Question to the Department of Health

    Helen Jones – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Helen Jones on 2016-09-14.

    To ask the Secretary of State for Health, (a) when and (b) by whom the decision was taken to withdraw funding for the NHS retirement fellowship; and what evidence on the health benefits of fellowship activities was considered prior to that decision being made.

    Mr Philip Dunne

    Health Education England (HEE) has, for the last two years, provided funding on behalf of the system to the NHS Retirement Fellowship. The funding was provided in support of the work they do for former employees of the National Health Service, however, the funding was always intended to be transitional support and not a guaranteed grant year on year. Like all publicly funded bodies, HEE is having to review its financial commitments and in turn, has prioritised funding for the education and training of the future workforce.